Jeffrey M. Leiden
2014 - Vertex Pharmaceuticals
|Non-Equity Incentive Plan||$2,970,000|
Leiden received $19.9M in stock awards, accounting for 54.27% of the total pay in 2014.
Leiden also received $3M in non-equity incentive plan, $12.7M in option awards, $1.1M in salary and $12.9K in other compensation.
34out of 12,947
Jeffrey M. Leiden's 2014 compensation ranked 34th out of 12,947 executive pay records tracked by us this year.
Leiden earned more than 99.7% of all executives tracked by us in 2014.
Ranking in industry group
3out of 1,319
In the industry group of Drugs, Leiden's pay ranked 3rd out of 1,319 executive pay records tracked by us in 2014.
Leiden earned more than 99.8% of executives in this group.
We found four more compensation records of executives who worked with Jeffrey M. Leiden at Vertex Pharmaceuticals in 2014.